Emory Team to Receive Grant to More Fully Understand and Release the Parking Brake!

The Hypersomnia Foundation congratulates Dr. David Rye and the team at Emory University on their receipt of a 4-year award for nearly $3 million in total costs from the National Institute of Neurological Disorders and Stroke to study the biologic basis of hypersomnia. This funding will enable the team to further characterize “an endogenous GABA-ergic mechanism underlying hypersomnia.” According to Dr. Rye’s grant application: “Sleepiness that persists after prolonged sleep (i.e., hypersomnia) is common, its socioeconomic burden significant, and its origins poorly understood. Recognition and treatment are inadequate. We have shown that the spinal fluid of patients disabled by sleepiness mimics sedative-hypnotic drug actions. Reversal with benzodiazepine antagonist drugs in vitro restores wakefulness to patients failing standard therapies. We propose to identify the molecule that is causal to this sleepiness and define its subcellular site of action relative to that targeted by conventional sedative/hypnotic drugs.”

As reported in their seminal 2012 Science Translational Medicine paper, Emory researchers have identified an “endogenous small peptide that dampens neural excitability by enhancing gamma-aminobutyric acid (GABA)—the brain’s principal inhibitory neurotransmitter. The [cerebrospinal fluid] of patients [with primary hypersomnias] exhibit normal GABA concentrations and amino acid profiles, and do not contain exogenous benzodiazepines by forensic liquid chromatography/mass spectrometry.”

This research has the potential to turn on its head our current understanding of how sleepiness occurs.

Parking brakeAs Dr. Rye is oft to paraphrase collaborator Dr. Andrew Jenkins, “The current treatment modalities for hypersomnia (that is, with psychostimulants or alternate agents that promote wake) are analogous to pushing the gas pedal of a car while the parking brake is engaged. . . no matter how much the drivers accelerate, they cannot fully overcome the parking brake. We need to better understand the parking brake—and how to release it—to bring more complete relief from hypersomnia.” In the words of the grant application, “The idea that hypersomnolence can arise from a gain of function of a naturally occurring humoral somnogen is a paradigm shift from concepts that posit a cause in loss of function of wake-promoting neural networks.”

Share Post

SomnusNooze Home Page

SomnusNooze Editions/Archives

The contents of this website, including text, graphics and other material, are for informational purposes only. This website is not intended to be a substitute for professional legal or medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Always consult your own attorney or other legal advisor with any legal questions you may have. The Hypersomnia Foundation does not recommend or endorse any specific tests, physicians, lawyers, legal advisors, products, procedures, opinions or other information referenced on this website. Reliance on any information on this website is solely at your own risk.

The Hypersomnia Foundation makes no representations or warranties about the satisfaction of any government regulations requiring disclosure of information on prescription drug products. In no event shall The Hypersomnia Foundation be liable for any damages (including without limitation incidental and consequential damages) or costs (including without limitation attorney’s fees) based on any claim arising from the use of this website and/or its content.